Urology & Nephrology News, Treatment Studies | Renal, Urology …
网页By John Schieszer, MA. A proposed 2025 Physician Fee Schedule conversion factor of $32.36 represents a 2.8% decrease from 2024.
MRI Predicts Prostate Cancer Upgrading at First Active Surveillance ...
网页4 天之前 — October 3, 2024. Baseline MRI PI-RADS score suggests prognosis and may improve upfront risk stratification and eligibility for prostate cancer active surveillance. Higher baseline MRI PI-RADS ...
Jardiance Approved for Adults With Chronic Kidney Disease
网页September 25, 2023. The Food and Drug Administration (FDA) has approved Jardiance ® (empagliflozin) to reduce the risk of sustained decline in estimated glomerular filtration rate (eGFR), end ...
Semaglutide Improves Kidney Outcomes in High-Risk Patients
网页2024年5月28日 — References: Perkovic V, Tuttle KR, Rossing P, et al. Effects of semaglutide on chronic kidney disease in patients with type diabetes. N Eng J Med.Published online May 24, 2024. doi:10.1056 ...
News Archive - Renal and Urology News
网页2024年9月30日 — Probiotic, Prebiotic, and Synbiotic Supplements Have Favorable Effect in MASLD. Researchers investigated the effect of microbiota therapy on the liver among patients with metabolic dysfunction ...
Olaparib Without ADT Benefits HRR-Mutated High-Risk Recurrent …
网页2024年8月30日 — Olaparib monotherapy for high-risk biochemically recurrent prostate cancer following radical prostatectomy has beneficial effects in patients with homologous recombination repair (HRR) alterations ...
Risk of Late Biochemical Recurrence “Strikingly Low” in Certain ...
网页6 天之前 — References: Hoeh B, Preisser F, Zattoni F, et al. Risk of biochemical recurrence and metastasis in prostate cancer patients treated with radical prostatectomy after a 10-year disease-free interval ...
Adjuvant Nivolumab Shows Durable Benefit in High-Risk MIUC
网页2022年6月2日 — The data show that nivolumab continued to maintain a clinically meaningful improvement in disease-free survival (DFS). CheckMate 274 included 709 patients with high-risk MIUC. Investigators ...
Regular SARS-CoV-2 Testing in Hemodialysis Facilities …
网页6 天之前 — References: Montez-Rath M, Varkila M, Yu X, et al. Acceptance of SARS-CoV-2 surveillance testing among patients receiving dialysis: a cluster randomized trial. JAMA Netw Open. 2024 Sep 3;7(9). doi ...
Water Vapor Therapy for BPH Safe, Effective in Large Real-World …
网页May 14, 2022. Real-world data confirm that RezÅ«m therapy, a minimally invasive procedure that uses water vapor to ablate prostate tissue, is safe and effective for treating benign prostatic ...